In the News

At Inlightened, Ramirez will lead growth strategy and will shape how the company works with market researchers, pharma insights teams and research service providers.

Inlightened has appointed Rob Ramirez as Head of Strategy, aimed at strengthening its growth strategy and expanding its services for pharmaceutical, biotech, and healthcare research clients.

We know fast, expert-driven innovation is possible. Inlightened President, Shelli Pavone, questions why it’s still the exception rather than the norm in everyday research and product development.

Inlightened expert Kameron Matthews, MD, JD, FAAFP and president Shelli Pavone join the Lifers podcast with host Christina Farr to talk Medicaid underpayment, licensing chaos, and the broken primary care economics that are harming patients and providers.

Executives and thought leaders say they expect to see wider, and more intentional, adoption of artificial intelligence across the industry.

Inlightened survey findings highlight a clear opportunity for healthcare and pharma marketers to equip clinicians to engage online.

Inlightened released survey findings that confirm what many clinicians feel in the exam room: Online influence is not just a nuisance; it is a direct threat to patient safety.

As artificial intelligence takes hold in healthcare, a growing number of Inlightened experts are sourced to help companies develop and test clinical models.

Inlightened President Shelli Pavone on the significant gaps between AI’s current implementation and full potential.